Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1984 1
1986 1
1987 2
1988 7
1989 3
1990 4
1991 2
1992 6
1993 5
1994 5
1995 8
1996 5
1997 16
1998 11
1999 19
2000 18
2001 20
2002 26
2003 29
2004 28
2005 32
2006 51
2007 68
2008 67
2009 60
2010 79
2011 107
2012 126
2013 101
2014 138
2015 125
2016 138
2017 140
2018 169
2019 235
2020 245
2021 231
2022 268
2023 291
2024 351
2025 418
2026 309

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,540 results

Results by year

Filters applied: . Clear all
Page 1
Lactobacillus reuteri in digestive system diseases: focus on clinical trials and mechanisms.
Peng Y, Ma Y, Luo Z, Jiang Y, Xu Z, Yu R. Peng Y, et al. Front Cell Infect Microbiol. 2023 Aug 18;13:1254198. doi: 10.3389/fcimb.2023.1254198. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37662007 Free PMC article. Review.
OBJECTIVES: Digestive system diseases have evolved into a growing global burden without sufficient therapeutic measures. Lactobacillus reuteri (L. reuteri) is considered as a new potential economical therapy for its probiotic effects in the gastrointestinal s …
OBJECTIVES: Digestive system diseases have evolved into a growing global burden without sufficient therapeutic measures. Lactobacillus …
Lactobacillus reuteri ZJ617 attenuates metabolic syndrome via microbiota-derived spermidine.
Ma Y, Zhong Y, Tang W, Valencak TG, Liu J, Deng Z, Mao J, Liu D, Wang S, Wang Y, Wang H. Ma Y, et al. Nat Commun. 2025 Jan 21;16(1):877. doi: 10.1038/s41467-025-56105-4. Nat Commun. 2025. PMID: 39837844 Free PMC article.
Here, we show that the supplementation of Lactobacillus reuteri ZJ617 ameliorates symptoms of MetS in mice induced by the high-fat diet. L. reuteri ZJ617 modulates host metabolism by interacting with the microbiome, resulting in the production of spermidine s …
Here, we show that the supplementation of Lactobacillus reuteri ZJ617 ameliorates symptoms of MetS in mice induced by the high …
Lactobacillus reuteri tryptophan metabolism promotes host susceptibility to CNS autoimmunity.
Montgomery TL, Eckstrom K, Lile KH, Caldwell S, Heney ER, Lahue KG, D'Alessandro A, Wargo MJ, Krementsov DN. Montgomery TL, et al. Microbiome. 2022 Nov 23;10(1):198. doi: 10.1186/s40168-022-01408-7. Microbiome. 2022. PMID: 36419205 Free PMC article.
We and others have previously shown that colonization with the gut commensal and putative probiotic species, Lactobacillus reuteri, unexpectedly enhances host susceptibility to experimental autoimmune encephalomyelitis (EAE), a murine model of multiple sclerosis. .. …
We and others have previously shown that colonization with the gut commensal and putative probiotic species, Lactobacillus reuteri …
Lactobacillus reuteri for chronic periodontitis: focus on underlying mechanisms and future perspectives.
Zhou K, Xie J, Su Y, Fang J. Zhou K, et al. Biotechnol Genet Eng Rev. 2024 Apr;40(1):381-408. doi: 10.1080/02648725.2023.2183617. Epub 2023 Mar 1. Biotechnol Genet Eng Rev. 2024. PMID: 36856460 Review.
Despite the wide use of antibiotics as the conventional adjunctive treatment, the challenges of increased antibiotic resistance and limited therapeutic effect receive considerable attention and the developments of alternative treatments gain increasing consideration. Growing evid …
Despite the wide use of antibiotics as the conventional adjunctive treatment, the challenges of increased antibiotic resistance and limited …
beta-Glucuronidase-Expressing Lactobacillus reuteri Triggers Irinotecan Enterotoxicity Through Depleting the Regenerative Epithelial Stem/Progenitor Pool.
Yue B, Gao R, Zhao L, Liu D, Lv C, Wang Z, Ai F, Zhang B, Yu Z, Geng X, Wang H, Wang K, Chen K, Liu C, Wang Z, Dou W. Yue B, et al. Adv Sci (Weinh). 2025 Jul;12(26):e2411052. doi: 10.1002/advs.202411052. Epub 2025 Apr 26. Adv Sci (Weinh). 2025. PMID: 40285661 Free PMC article.
Microbiome profiling of clinical patients and mucositis mice revealed a strong correlation between CPT11/SN38 enterotoxicity and GUS-expressing bacteria, particularly Lactobacillus reuteri. PLS-PM modeling further linked L. reuteri to impaired epithelial rege …
Microbiome profiling of clinical patients and mucositis mice revealed a strong correlation between CPT11/SN38 enterotoxicity and GUS-express …
Polyphenols and Lactobacillus reuteri in oral health.
Naureen Z, Medori MC, Dhuli K, Donato K, Connelly ST, Bellinato F, Gisondi P, Bertelli M. Naureen Z, et al. J Prev Med Hyg. 2022 Oct 17;63(2 Suppl 3):E246-E254. doi: 10.15167/2421-4248/jpmh2022.63.2S3.2767. eCollection 2022 Jun. J Prev Med Hyg. 2022. PMID: 36479495 Free PMC article. Review.
Therefore, plant-derived molecules - such as polyphenols - and probiotics - such as Lactobacillus reuteri - have shown a significant potential in treating and curing oral diseases, either alone or in combination, owing to their antioxidant and antimicrobial properti …
Therefore, plant-derived molecules - such as polyphenols - and probiotics - such as Lactobacillus reuteri - have shown a signi …
Lactobacillus reuteri in Its Biofilm State Improves Protection from Experimental Necrotizing Enterocolitis.
Al-Hadidi A, Navarro J, Goodman SD, Bailey MT, Besner GE. Al-Hadidi A, et al. Nutrients. 2021 Mar 12;13(3):918. doi: 10.3390/nu13030918. Nutrients. 2021. PMID: 33809097 Free PMC article. Review.
We present a novel formulation of enterally delivered probiotics that addresses the current limitations. A single enteral dose of Lactobacillus reuteri delivered in a biofilm formulation increases probiotic survival in acidic gastric conditions, increases probiotic …
We present a novel formulation of enterally delivered probiotics that addresses the current limitations. A single enteral dose of Lactoba …
Ningxiang pig-derived lactobacillus reuteri modulates host intramuscular fat deposition via branched-chain amino acid metabolism.
Yang M, Xie Q, Wang J, Zha A, Chen J, Jiang Q, Kang M, Deng Q, Yin Y, Tan B. Yang M, et al. Microbiome. 2025 Jan 31;13(1):32. doi: 10.1186/s40168-024-02013-6. Microbiome. 2025. PMID: 39891238 Free PMC article.
Additionally, it has been verified that L. reuteri originating from NX pigs has the ability to improve BCAA synthesis in the gut and enhance IMF content in lean DLY pigs. ...CONCLUSIONS: Taken together, our results imply that NX pig-derived L. reuteri regulates BCAA …
Additionally, it has been verified that L. reuteri originating from NX pigs has the ability to improve BCAA synthesis in the gut and …
Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin?
Saviano A, Brigida M, Migneco A, Gunawardena G, Zanza C, Candelli M, Franceschi F, Ojetti V. Saviano A, et al. Medicina (Kaunas). 2021 Jun 23;57(7):643. doi: 10.3390/medicina57070643. Medicina (Kaunas). 2021. PMID: 34201542 Free PMC article. Review.
Background and Objectives: Lactobacillus reuteri DSM 17938 (L. reuteri) is a probiotic that can colonize different human body sites, including primarily the gastrointestinal tract, but also the urinary tract, the skin, and breast milk. ...In both children and …
Background and Objectives: Lactobacillus reuteri DSM 17938 (L. reuteri) is a probiotic that can colonize different huma …
Lactobacillus reuteri growth and fermentation under high pressure towards the production of 1,3-propanediol.
Mota MJ, Lopes RP, Sousa S, Gomes AM, Delgadillo I, Saraiva JA. Mota MJ, et al. Food Res Int. 2018 Nov;113:424-432. doi: 10.1016/j.foodres.2018.07.034. Epub 2018 Jul 27. Food Res Int. 2018. PMID: 30195537 Review.
Lactobacillus reuteri is a lactic acid bacterium able to produce several relevant bio-based compounds, including 1,3-propanediol (1,3-PDO), a compound used in food industry for a wide range of purposes. ...Therefore, the present work intended to evaluate the effects …
Lactobacillus reuteri is a lactic acid bacterium able to produce several relevant bio-based compounds, including 1,3-propanedi …
3,540 results